BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32497495)

  • 1. POLE Mutation Spectra Are Shaped by the Mutant Allele Identity, Its Abundance, and Mismatch Repair Status.
    Hodel KP; Sun MJS; Ungerleider N; Park VS; Williams LG; Bauer DL; Immethun VE; Wang J; Suo Z; Lu H; McLachlan JB; Pursell ZF
    Mol Cell; 2020 Jun; 78(6):1166-1177.e6. PubMed ID: 32497495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D.
    Timmerman S; Van Rompuy AS; Van Gorp T; Vanden Bempt I; Brems H; Van Nieuwenhuysen E; Han SN; Neven P; Victoor J; Laenen A; Vergote I
    Gynecol Oncol; 2020 Apr; 157(1):245-251. PubMed ID: 31980219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Pol ε-dependent replication errors and the influence of mismatch repair on their correction.
    Agbor AA; Göksenin AY; LeCompte KG; Hans SH; Pursell ZF
    DNA Repair (Amst); 2013 Nov; 12(11):954-63. PubMed ID: 24051051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational processes of distinct POLE exonuclease domain mutants drive an enrichment of a specific TP53 mutation in colorectal cancer.
    Fang H; Barbour JA; Poulos RC; Katainen R; Aaltonen LA; Wong JWH
    PLoS Genet; 2020 Feb; 16(2):e1008572. PubMed ID: 32012149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline
    Lindsay H; Scollon S; Reuther J; Voicu H; Rednam SP; Lin FY; Fisher KE; Chintagumpala M; Adesina AM; Parsons DW; Plon SE; Roy A
    Cold Spring Harb Mol Case Stud; 2019 Oct; 5(5):. PubMed ID: 31624068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer.
    Church DN; Briggs SE; Palles C; Domingo E; Kearsey SJ; Grimes JM; Gorman M; Martin L; Howarth KM; Hodgson SV; ; Kaur K; Taylor J; Tomlinson IP
    Hum Mol Genet; 2013 Jul; 22(14):2820-8. PubMed ID: 23528559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Analysis of Cancer-Associated DNA Polymerase ε Variants in
    Barbari SR; Kane DP; Moore EA; Shcherbakova PV
    G3 (Bethesda); 2018 Mar; 8(3):1019-1029. PubMed ID: 29352080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. POLE/POLD1 mutation and tumor immunotherapy.
    Ma X; Dong L; Liu X; Ou K; Yang L
    J Exp Clin Cancer Res; 2022 Jul; 41(1):216. PubMed ID: 35780178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA polymerase ε and δ variants drive mutagenesis in polypurine tracts in human tumors.
    Ostroverkhova D; Tyryshkin K; Beach AK; Moore EA; Masoudi-Sobhanzadeh Y; Barbari SR; Rogozin IB; Shaitan KV; Panchenko AR; Shcherbakova PV
    Cell Rep; 2024 Jan; 43(1):113655. PubMed ID: 38219146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Molecular and Immunohistochemical Analyses of Endometrial Clear Cell Carcinoma Show that POLE Mutations and DNA Mismatch Repair Protein Deficiencies Are Uncommon.
    Baniak N; Fadare O; Köbel M; DeCoteau J; Parkash V; Hecht JL; Hanley KZ; Gwin K; Zheng W; Quick CM; Jarboe EA; Liang SX; Kinloch M
    Am J Surg Pathol; 2019 Apr; 43(4):531-537. PubMed ID: 30585826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer.
    Stasenko M; Tunnage I; Ashley CW; Rubinstein MM; Latham AJ; Da Cruz Paula A; Mueller JJ; Leitao MM; Friedman CF; Makker V; Soslow RA; DeLair DF; Hyman DM; Zamarin D; Alektiar KM; Aghajanian CA; Abu-Rustum NR; Weigelt B; Cadoo KA
    Gynecol Oncol; 2020 Jan; 156(1):194-202. PubMed ID: 31757464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline PMS2 and somatic POLE exonuclease mutations cause hypermutability of the leading DNA strand in biallelic mismatch repair deficiency syndrome brain tumours.
    Andrianova MA; Chetan GK; Sibin MK; Mckee T; Merkler D; Narasinga RK; Ribaux P; Blouin JL; Makrythanasis P; Seplyarskiy VB; Antonarakis SE; Nikolaev SI
    J Pathol; 2017 Nov; 243(3):331-341. PubMed ID: 28805995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction between cytosine methylation and processes of DNA replication and repair shape the mutational landscape of cancer genomes.
    Poulos RC; Olivier J; Wong JWH
    Nucleic Acids Res; 2017 Jul; 45(13):7786-7795. PubMed ID: 28531315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological characteristics of POLE mutation in patients with non-small-cell lung cancer.
    Song Z; Cheng G; Xu C; Wang W; Shao Y; Zhang Y
    Lung Cancer; 2018 Apr; 118():57-61. PubMed ID: 29572003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymerase epsilon mutations and concomitant β2-microglobulin mutations in cancer.
    Voutsadakis IA
    Gene; 2018 Mar; 647():31-38. PubMed ID: 29320758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Di-genic inheritance of germline POLE and PMS2 pathogenic variants causes a unique condition associated with pediatric cancer predisposition.
    Michaeli O; Ladany H; Erez A; Ben Shachar S; Izraeli S; Lidzbarsky G; Basel-Salmon L; Biskup S; Maruvka YE; Toledano H; Goldberg Y
    Clin Genet; 2022 Apr; 101(4):442-447. PubMed ID: 34967012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53, Mismatch Repair Protein, and POLE Abnormalities in Ovarian Clear Cell Carcinoma: An Outcome-based Clinicopathologic Analysis.
    Parra-Herran C; Bassiouny D; Lerner-Ellis J; Olkhov-Mitsel E; Ismiil N; Hogen L; Vicus D; Nofech-Mozes S
    Am J Surg Pathol; 2019 Dec; 43(12):1591-1599. PubMed ID: 31335355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological, immunophenotypical and molecular features of hypermutation in colorectal carcinomas with mutations in DNA polymerase ε (POLE).
    Forgó E; Gomez AJ; Steiner D; Zehnder J; Longacre TA
    Histopathology; 2020 Feb; 76(3):366-374. PubMed ID: 31479159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability.
    Haruma T; Nagasaka T; Nakamura K; Haraga J; Nyuya A; Nishida T; Goel A; Masuyama H; Hiramatsu Y
    PLoS One; 2018; 13(4):e0195655. PubMed ID: 29659608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. POLE, MMR, and MSI Testing in Endometrial Cancer: Proceedings of the ISGyP Companion Society Session at the USCAP 2020 Annual Meeting.
    Casey L; Singh N
    Int J Gynecol Pathol; 2021 Jan; 40(1):5-16. PubMed ID: 33290350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.